Crohn’s Disease

October 3, 2014October 3, 2014

Further Data Support Safety, Efficacy of Takeda’s Entyvio for UC, Crohn’s

Crohn's Disease, News, Ulcerative colitis

Takeda Pharmaceuticals, which is on the forefront of treating ulcerative colitis and Crohn’s disease with the newly launched Entyvio (vedolizumab), will present data concerning the open-label extension phase 3 study ... Read more

October 3, 2014October 3, 2014

Clinical Decision Support Tool Published by AGA for Crohn’s Disease Physicians

Crohn's Disease, News

The American Gastroenterologial Association (AGA) recently created a clinical decision tool to help gastroenterologists both identify and manage Crohn’s disease in their patients. “Identification, Assessment, and Initial Medical Treatment in Crohn’s Disease Clinical ... Read more

September 30, 2014September 30, 2014

Takeda’s CD and UC Therapy Receives Positive Reaction from U.S. Gastroenterologists

Crohn's Disease, News, Ulcerative colitis

One month after the launch of Entyvio, a new treatment for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD), the therapy is already becoming a popular prescription among gastroenterologists ... Read more

September 26, 2014September 26, 2014

FDA Approves Humira for Pediatric Crohn’s Disease

Crohn's Disease, News

Abbvie reported today that the U.S. Food and Drug Administration (FDA) has approved HUMIRA® (adalimumab) as a new treatment for Crohn’s disease in children over six years of age, when other treatments ... Read more

September 24, 2014September 24, 2014

New IBD Researchers Connects Crohn’s Disease With Cervical Neoplasia

Crohn's Disease, News

A recent study entitled “Inflammatory Bowel Disease and Cervical Neoplasia: A Population-Based Nationwide Cohort Study” published in Clinical Gastroenterology and Hepatology reported a new link between Crohn’s disease and uterine ... Read more

September 23, 2014September 23, 2014

Texas A&M Student is Tyler’s Honored Hero for Her Crohn’s Disease Advocacy

Crohn's Disease, News

Inflammatory bowel disease (IBD) can be a debilitating condition. It causes extreme discomfort, a number of health complications, and can greatly reduce one’s quality of life. A college student diagnosed ... Read more

September 19, 2014September 19, 2014

Epigenetic Changes In Crohn’s Disease Patients’ DNA Could Help Screen For The Disease

Crohn's Disease, News

Epigenetic changes in the DNA of patients with Crohn’s disease may provide important insight into how the disease develops depending on interactions between genetics and environmental factors (such as diet ... Read more

September 18, 2014September 18, 2014

New Survey Suggests Biologics Could Be the New Vanguard For Treating Crohn’s Disease, Ulcerative Colitis

Crohn's Disease, News, Ulcerative colitis

In their latest report, entitled, “Crohn’s Disease and Ulcerative Colitis: U.S. Physician and Payer Perspectives on Established and Recently Launched Biologics, Emerging Novel Agents and Biosimilars,” Decision Resources, a Decision ... Read more

September 17, 2014September 17, 2014

AGA Publishes Guide to Help Physicians Treat Crohn’s Disease Patients

Crohn's Disease, News

The American Gastroenterological Association (AGA) recently developed a guide to assist gastroenterologists in the diagnosis and treatment choices for Crohn’s disease patients, as well as to help them support their clinical decisions, called ... Read more

September 10, 2014September 10, 2014

European Medicines Agency Gives Positive Opinion on TiGenix’s Pediatric Investigation Plan For CD Perianal Fistulas Treatment

Crohn's Disease, News

Biopharmaceutical company TiGenix NV, which is currently developing and commercializing novel therapeutics from its proprietary platform of allogeneic, expanded adipose-derived stem cells (eASC’s) for inflammatory and autoimmune diseases, announced that it received ... Read more